OCGN
Price
$1.40
Change
+$0.08 (+6.06%)
Updated
May 3, 10:34 AM EST
Earnings call today
PHAT
Price
$10.04
Change
+$0.28 (+2.87%)
Updated
May 3, 10:43 AM EST
6 days until earnings call
Ad is loading...

Analysis and predictions OCGN vs PHAT

Header iconOCGN vs PHAT Comparison
Open Charts OCGN vs PHATBanner chart's image
Ocugen
Price$1.40
Change+$0.08 (+6.06%)
Volume$1.8K
CapitalizationN/A
Phathom Pharmaceuticals
Price$10.04
Change+$0.28 (+2.87%)
Volume$700
CapitalizationN/A
View a ticker or compare two or three
OCGN vs PHAT Comparison Chart

Loading...

OCGNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PHATDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
OCGN vs. PHAT commentary
May 03, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OCGN is a Hold and PHAT is a StrongBuy.

COMPARISON
Comparison
May 03, 2024
Stock price -- (OCGN: $1.32 vs. PHAT: $9.76)
Brand notoriety: OCGN and PHAT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OCGN: 54% vs. PHAT: 136%
Market capitalization -- OCGN: $339.67M vs. PHAT: $570.61M
OCGN [@Biotechnology] is valued at $339.67M. PHAT’s [@Biotechnology] market capitalization is $570.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $559.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.61B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OCGN’s FA Score shows that 0 FA rating(s) are green whilePHAT’s FA Score has 0 green FA rating(s).

  • OCGN’s FA Score: 0 green, 5 red.
  • PHAT’s FA Score: 0 green, 5 red.
According to our system of comparison, OCGN is a better buy in the long-term than PHAT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OCGN’s TA Score shows that 4 TA indicator(s) are bullish while PHAT’s TA Score has 4 bullish TA indicator(s).

  • OCGN’s TA Score: 4 bullish, 5 bearish.
  • PHAT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both OCGN and PHAT are a bad buy in the short-term.

Price Growth

OCGN (@Biotechnology) experienced а +11.86% price change this week, while PHAT (@Biotechnology) price change was +7.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.32%. For the same industry, the average monthly price growth was -0.52%, and the average quarterly price growth was +1244.27%.

Reported Earning Dates

OCGN is expected to report earnings on Aug 02, 2024.

PHAT is expected to report earnings on Aug 08, 2024.

Industries' Descriptions

@Biotechnology (+5.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for OCGN with price predictions.
OPEN
A.I.dvisor published
a Summary for PHAT with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
PHAT($571M) has a higher market cap than OCGN($340M). OCGN YTD gains are higher at: 129.565 vs. PHAT (6.900).
OCGNPHATOCGN / PHAT
Capitalization340M571M60%
EBITDAN/AN/A-
Gain YTD129.5656.9001,878%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
OCGN: Fundamental Ratings
OCGN
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
OCGNPHAT
RSI
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
73%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 1 day ago
86%
Declines
ODDS (%)
Bearish Trend 16 days ago
86%
Bearish Trend 15 days ago
84%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Ad is loading...
OCGNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PHATDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSVRX42.080.67
+1.62%
Columbia Small Cap Value I R
VSQAX16.310.09
+0.55%
Invesco MSCI World SRI Index A
SWDSX14.470.05
+0.35%
Schwab Dividend Equity
TRLIX21.190.06
+0.28%
Nuveen Large Cap Value Instl
GQHIX12.290.03
+0.24%
GQG Partners US Quality Dividend Inc Ins

OCGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCGN has been loosely correlated with MDGL. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if OCGN jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCGN
1D Price
Change %
OCGN100%
-5.04%
MDGL - OCGN
51%
Loosely correlated
+2.59%
ARRY - OCGN
47%
Loosely correlated
+4.82%
AXON - OCGN
46%
Loosely correlated
+1.66%
XNCR - OCGN
36%
Loosely correlated
-1.25%
PHAT - OCGN
35%
Loosely correlated
+5.40%
More